Is Age the Most Important Risk Factor in COVID-19 Patients? The Relevance of Comorbidity Burden: A Retrospective Analysis of 10,551 Hospitalizations

References

• Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:26. doi:10.1136/bmj.m1328
   Web of Science ®Google Scholar
• Starke KR, Petereit-Haack G, Schubert M, et al. The age-related risk of severe outcomes due to covid-19 infection: a rapid review, meta-analysis, and meta-regression. Int J Environ Res Public Health. 2020;17(16):1–24. doi:10.3390/ijerph17165974
   Web of Science ®Google Scholar
• Ho FK, Petermann-Rocha F, Gray SR, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One. 2020;15(11 November):e0241824. doi:10.1371/journal.pone.0241824
   PubMed Web of Science ®Google Scholar
• Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003–e1017. doi:10.1016/S2214-109X(20)30264-3
   PubMed Web of Science ®Google Scholar
• Semenzato L, Botton J, Drouin J, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health. 2021;8:100158. doi:10.1016/j.lanepe.2021.100158
   PubMedGoogle Scholar
• Henkens MTHM, Raafs AG, Verdonschot JAJ, et al. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatr. 2022;22(1):1–11. doi:10.1186/S12877-021-02673-1
   PubMed Web of Science ®Google Scholar
• Gupta RK, Marks M, Samuels THA, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020;56(6):2003498. doi:10.1183/13993003.03498-2020
   PubMed Web of Science ®Google Scholar
• Chang E-S, Kannoth S, Levy S, Wang S-Y, Lee JE, Levy BR. Global reach of ageism on older persons’ health: a systematic review. PLoS One. 2020;15(1):e0220857. doi:10.1371/journal.pone.0220857
   PubMed Web of Science ®Google Scholar
• Ehni H-J, Wahl H-W. Six propositions against ageism in the COVID-19 pandemic. J Aging Soc Policy. 2020;32(4–5):515–525. doi:10.1080/08959420.2020.1770032
   PubMed Web of Science ®Google Scholar
• Gidari A, De Socio GV, Sabbatini S, Francisci D. Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection. Infect Dis. 2020;52(10):698–704. doi:10.1080/23744235.2020.1784457
   PubMed Web of Science ®Google Scholar
• Huang H, Cai S, Li Y, et al. Prognostic factors for COVID-19 Pneumonia progression to severe symptoms based on earlier clinical features: a retrospective analysis. Front Med. 2020;7. doi:10.3389/FMED.2020.557453
   Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi:10.1016/S0140-6736(20)31189-2
   PubMed Web of Science ®Google Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1966
   PubMed Web of Science ®Google Scholar
• Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score. BMJ. 2020;370:22. doi:10.1136/bmj.m3339
   Web of Science ®Google Scholar
• Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089. doi:10.1001/JAMAINTERNMED.2020.2033
   PubMed Web of Science ®Google Scholar
• Zou X, Li S, Fang M, et al. Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019. Crit Care Med. 2020;48(8):E657–E665. doi:10.1097/CCM.0000000000004411
   PubMed Web of Science ®Google Scholar
• Stalter RM, Atluri V, Xia F, et al. Elucidating pathways mediating the relationship between male sex and COVID-19 severity. Clin Epidemiol. 2022;14:115–125. doi:10.2147/clep.s335494
   PubMed Web of Science ®Google Scholar
• Qeadan F, VanSant-Webb E, Tingey B, et al. Racial disparities in COVID-19 outcomes exist despite comparable elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites. Sci Rep. 2021;11(1). doi:10.1038/S41598-021-88308-2
   PubMed Web of Science ®Google Scholar
• De Caprio D, Gartner J, McCall CJ, et al. Building a COVID-19 vulnerability index. J Med Artif Intell. 2020;3. doi:10.21037/JMAI-20-47
   Google Scholar
• Cho SI, Yoon S, Lee HJ. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database. Sci Rep. 2021;11(1). doi:10.1038/S41598-021-85813-2
   Web of Science ®Google Scholar
• Ioannou GN, Locke E, Green P, et al. Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection. JAMA Netw Open. 2020;3(9):e2022310–e2022310. doi:10.1001/JAMANETWORKOPEN.2020.22310
   PubMed Web of Science ®Google Scholar
• Gulbech Ording A, Toft Sørensen H. Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs. Clin Epidemiol. 2013;5(1):199–203. doi:10.2147/CLEP.S45305
   PubMedGoogle Scholar
• Monterde D, Cainzos-Achirica M, Cossio-Gil Y, et al. Performance of comprehensive risk adjustment for the prediction of in-hospital events using administrative healthcare data: the queralt indices. Risk Manag Healthc Policy. 2020;13:271–283. doi:10.2147/RMHP.S228415
   PubMed Web of Science ®Google Scholar
• Monterde D, Carot-Sans G, Cainzos-Achirica M, et al. Performance of three measures of comorbidity in predicting critical covid-19: a retrospective analysis of 4607 hospitalized patients. Risk Manag Healthc Policy. 2021;14:4729–4737. doi:10.2147/RMHP.S326132
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Clin Epidemiol. 1987;40(5):373–383.
   Google Scholar
• Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-00004
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83
   PubMed Web of Science ®Google Scholar
• Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ elixhauser comorbidity index. Med Care. 2017;55(7):698–705. doi:10.1097/MLR.0000000000000735
   PubMed Web of Science ®Google Scholar
• Roso-Llorach A, Serra-Picamal X, Cos FX, et al. Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain. Glob Epidemiol. 2022;4:100071. doi:10.1016/j.gloepi.2022.100071
   PubMedGoogle Scholar
• Imai K, Keele L, Yamamoto T. Identification, inference and sensitivity analysis for causal mediation effects. Statist Sci. 2010;25(1):51–71. doi:10.1214/10-STS321
   Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021. Available from: https://www.r-project.org. Accessed December 20, 2021.
   Google Scholar
• Tingley D. Mediation: R package for causal mediation analysis. R package version 4.5.0. Available from: http://cran.r-project.org/package=mediation. Accessed February 28, 2022.
   Google Scholar
• Bates D, Maechler M, Bolker BM, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1–48. doi:10.18637/jss.v067.i01
   Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):1–8. doi:10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Grau J, Grosse I, Keilwagen J. PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R. Bioinformatics. 2015;31(15):2595–2597. doi:10.1093/bioinformatics/btv153
   PubMed Web of Science ®Google Scholar
• Gasparini A. Package “comorbidity”; 2020. Available from: https://cran.r-project.org/web/packages/comorbidity/comorbidity.pdf. Accessed January 20, 2021.
   Google Scholar
• Goodman KE, Magder LS, Baghdadi JD, et al. Impact of sex and metabolic comorbidities on coronavirus disease 2019 (COVID-19) mortality risk across age groups: 66 646 inpatients across 613 US hospitals. Clin Infect Dis. 2021;73(11):e4113–e4123. doi:10.1093/cid/ciaa1787
   PubMed Web of Science ®Google Scholar
• Bae S, Kim SR, Kim M-N, Shim WJ, Park S-M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107(5):373–380. doi:10.1136/heartjnl-2020-317901
   PubMed Web of Science ®Google Scholar
• Molani S, Hernandez PV, Roper RT, et al. Risk factors for severe COVID-19 differ by age for hospitalized adults. Sci Rep. 2022;12(1):6568. doi:10.1038/s41598-022-10344-3
   PubMed Web of Science ®Google Scholar
• Awortwe C, Cascorbi I. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions. Pharmacol Res. 2020;161:105250. doi:10.1016/j.phrs.2020.105250
   PubMed Web of Science ®Google Scholar
• Qiu P, Zhou Y, Wang F, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020;32(9):1869–1878. doi:10.1007/S40520-020-01664-3
   PubMed Web of Science ®Google Scholar
• Chen Z, Peng Y, Wu X, et al. Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: a systematic review and meta-analysis. Front Public Health. 2022;10:1.
   Web of Science ®Google Scholar
• Péterfi A, Mészáros Á, Szarvas Z, et al. Comorbidities and increased mortality of COVID-19 among the elderly: a systematic review. Physiol Int. 2022. doi:10.1556/2060.2022.00206
   PubMed Web of Science ®Google Scholar
• Tian Y, Wu Q, Li H, et al. Distinct symptoms and underlying comorbidities with latitude and longitude in COVID-19: a systematic review and meta-analysis. Can Respir J. 2020;2022. doi:10.1155/2022/6163735
   Web of Science ®Google Scholar
• Thakur B, Dubey P, Benitez J, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 2021;11(1):1–13. doi:10.1038/s41598-021-88130-w
   PubMed Web of Science ®Google Scholar
• Mannucci E, Silverii GA, Monami M. Saturation of critical care capacity and mortality in patients with the novel coronavirus (COVID-19) in Italy. Trends Anaesth Crit Care. 2020;33:33. doi:10.1016/j.tacc.2020.05.002
   Web of Science ®Google Scholar
• Hick JL, Hanfling D, Wynia MK, Pavia AT. Duty to plan: health care, crisis standards of care, and novel coronavirus SARS-CoV-2. NAM Perspect. 2020;2020. doi:10.31478/202003b
   PubMedGoogle Scholar
• Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64(1):36–47. doi:10.1159/000512592
   Web of Science ®Google Scholar
• Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116(14):2197–2206. doi:10.1093/cvr/cvaa284
   PubMed Web of Science ®Google Scholar
• Vela E, Carot-Sans G, Clèries M, et al. Development and validation of a population-based risk stratification model for COVID-19 in the general population. Sci Rep. 2022;12:3277. doi:10.1038/s41598-022-07138-y
   PubMedGoogle Scholar
• Saragih ID, Advani S, Saragih IS, Suarilah I, Susanto I, Lin CJ. Frailty as a mortality predictor in older adults with COVID-19: a systematic review and meta-analysis of cohort studies. Geriatr Nurs. 2021;42(5):983–992. doi:10.1016/j.gerinurse.2021.06.003
   PubMed Web of Science ®Google Scholar
• Hussien H, Nastasa A, Apetrii M, Nistor I, Petrovic M, Covic A. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones. BMC Geriatr. 2021;21(1). doi:10.1186/s12877-021-02316-5
   PubMed Web of Science ®Google Scholar
• Bliek-Bueno K, Mucherino S, Poblador-Plou B, et al. Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy. Int J Environ Res Public Health. 2021;18(22):11786. doi:10.3390/ijerph182211786
   PubMed Web of Science ®Google Scholar
• Gude-Sampedro F, Fernández-Merino C, Ferreiro L, et al. Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study. Int J Epidemiol. 2021;50(1):64–74. doi:10.1093/ije/dyaa209
   PubMed Web of Science ®Google Scholar